Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Other Non-Current Liabilities (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Other Non-Current Liabilities for 13 consecutive years, with $199000.0 as the latest value for Q3 2025.

  • Quarterly Other Non-Current Liabilities fell 47.49% to $199000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $199000.0 through Sep 2025, down 47.49% year-over-year, with the annual reading at $96000.0 for FY2024, 91.54% down from the prior year.
  • Other Non-Current Liabilities hit $199000.0 in Q3 2025 for STRATA Skin Sciences, down from $264000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $8.6 million in Q1 2022 to a low of $24000.0 in Q1 2021.
  • Historically, Other Non-Current Liabilities has averaged $2.7 million across 5 years, with a median of $454000.0 in 2021.
  • Biggest five-year swings in Other Non-Current Liabilities: soared 35825.0% in 2022 and later plummeted 94.09% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $428000.0 in 2021, then soared by 1841.36% to $8.3 million in 2022, then plummeted by 86.34% to $1.1 million in 2023, then crashed by 91.54% to $96000.0 in 2024, then soared by 107.29% to $199000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for SSKN at $199000.0 in Q3 2025, $264000.0 in Q2 2025, and $96000.0 in Q1 2025.